OCBCO
XBI icon

Oversea-Chinese Banking Corp (OCBC)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,500
Closed -$447K – 409
2026
Q1 		$447K Sell
3,500
-45,151
-93% -$5.64M 0.01% 280
2025
Q4 		$5.93M Buy
48,651
+694
+1% +$79.6K 0.16% 98
2025
Q3 		$4.8M Buy
+47,957
New +$4.32M 0.12% 109

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s XBI Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 3,500 shares — an estimated $447K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in XBI in Q3 2025 and held it in 3 quarters. The position peaked at $5.93M in Q4 2025. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 3,500 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $447K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in State Street SPDR S&P Biotech ETF in Q3 2025 and held it in 3 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s State Street SPDR S&P Biotech ETF position peaked at $5.93M in Q4 2025.
  • 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.